SCCT2024 exhibit hall to showcase the latest in AI, workflow solutions

ARLINGTON, VA (June 12, 2024) — Key innovations, streamlining processes and advances in the field of cardiac computed tomography (CT) will be on display from the industry’s top medical device companies during the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting (SCCT2024), to be held July 18 - 21 in Washington, DC. 

SCCT’s industry partners – including Cleerly, GE HealthCare, HeartFlow and Siemens Healthineers – said they look forward to introducing practitioners to their newest products and services, including advances in photon-counting CT and dual-source CT, as well as programs that streamline and simplify workflows by leveraging artificial intelligence (AI).

“We look forward to SCCT every year because it’s a time to connect with our community of dedicated and passionate healthcare leaders. As a mission-driven organization, we share in SCCT’s commitment to the promotion and advocacy of research, education, and clinical excellence in cardiovascular computed tomography,” said James Min, MD, CEO and Founder of Cleerly.

Cleerly 

“At Cleerly, our aim is to provide practitioners and patients with the best possible solutions to support the evaluation of coronary heart disease and validate these with the highest-quality research. Our technology effectively translates advanced imaging into understandable clinical insights and equips practitioners and patients with cutting-edge tools in the fight to end heart attacks,” Dr. Min said. 

At SCCT2024 | Booth 201

• Cleerly® ISCHEMIA™: Cleerly ISCHEMIA is a commercially, FDA-cleared medical device that leverages latest-generation AI to aid in the diagnosis of coronary artery ischemia. Cleerly ISCHEMIA also allows for comprehensive lesion-by-lesion mapping of each lesion in a coronary artery, and a non-invasive analogue to important CAD measures that can help support clinical decision making related to coronary revascularization and how a specialist may treat a patient or lesion. Come hear experts discuss this innovative approach towards determining ischemia, see the latest large-scale clinical data that supports its differentiated diagnostic and prognostic utility over legacy methods, and understand the positive coverage and reimbursement available for this service.
  
  
• Cleerly’s Advanced Plaque Analysis: With an array of clinical trials, Cleerly’s advanced plaque analysis has been tested against nearly all invasive ground truth ‘gold standards’ for measures of angiographic stenosis, plaque burden, lipid rich plaque, vascular morphology and coronary ischemia. Come experience a new era in non-invasive CAD evaluation!

• Cleerly’s All in One Digital Care Pathway: Together, Cleerly’s products and services have been designed and implemented to be a CAD care management platform for comprehensive evaluation, education, treatment and tracking of heart disease. The Cleerly Care Pathway allows for a standardized approach to precision heart care for all stakeholders in the care pathway, including imaging physicians, general cardiologists, interventional cardiologists, primary care physicians, advanced practice providers and most importantly, patients.

About

Cleerly is the company on a mission to eliminate heart attacks by creating a new standard of care for heart disease. Through its FDA-cleared solutions driven by artificial intelligence, Cleerly supports comprehensive phenotyping of coronary artery disease, as determined from advanced non-invasive CT imaging. Cleerly’s approach is grounded in science, based on over 10 million images from over 40,000 patients gathered over a 15-year-period in landmark, multicenter clinical trials. Led by a world-class clinical and technical team, Cleerly enhances health literacy for each and every stakeholder in the coronary care pathway.

Press contact
press@cleerlyhealth.com

More information
cleerlyhealth.com

GE HealthCare 

At SCCT2024 | Booth 107

• Revolution Apex Platform: The Revolution Apex platform was built with exceptional technologies throughout the imaging chain and with an Effortless Workflow model of efficiency to help you meet your imaging challenges. To meet tomorrow’s needs, we’ve built it with scalable detectors that allow you to take your practice to the next level at any time. The Revolution Apex platform is the powerful, adaptable technology you need to lead CT now and into the future.

• Effortless Workflow: When it comes to CT, GE HealthCare studied the entire workflow and created solutions to simplify and streamline each step of the process. These solutions are the core of the Effortless Workflow model, a sophisticated collection of technologies that automate and simplify time-consuming tasks from pre-scan to post-scan. Effortless Workflow takes the CT experience to a new level.

• ECG-Less Cardiac: ECG-less Cardiac is a feature made available on the GE HealthCare Revolution Apex platform. Utilizing a 160 mm scan coverage, 0.23 sec rotation speed, SmartPhase and SnapShot Freeze 2 applications this feature allows for the scanner to acquire a motion free CCTA image without the aid of the patients’ ECG signal/trace.

About 

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Press contact
Anna Flahaven, Senior Product Marketing Manager, Computed Tomography anna.flahaven@gehealthcare.com

More information 
www.GEhealthcare.com

HeartFlow, Inc.

At SCCT2024 | Booth 101

• The DECIDE Registry, the largest prospective registry of its kind, will build upon clinical data supporting the use of plaque insights to empower clinical decision making for patients with suspected coronary artery disease.
• The HeartFlow ONE portfolio helps clinicians quickly and efficiently diagnose CAD and optimize treatment. RoadMap™ Analysis drives CCTA reading efficiency and consistency, FFRCT Analysis guides treatment planning, and Plaque Analysis characterizes and quantifies coronary atherosclerosis.
• HeartFlow's technology is guideline-recommended for optimal care and has helped clinicians diagnose and manage over 250,000 patients across over 850 hospitals.
  

About

HeartFlow is transforming precision coronary care with the only AI-powered non-invasive integrated heart care solution across the CCTA pathway. As the pioneer of FFRCT, which is now supported by the ACC/AHA Chest Pain Guideline, HeartFlow continues to advance the diagnosis and management of CAD. HeartFlow’s suite of non-invasive technologies includes its FFRCT Analysis, RoadMap™Analysis, and Plaque Analysis. To date, more than 500 peer-reviewed publications have validated our approach and, more importantly, our technologies have helped clinicians diagnose and manage over 250,000 patients.

Press contact
Linly Ku 
lku@heartflow.com
 
More information 
www.heartflow.com

Siemens Healthineers

“Siemens Healthineers shares SCCT’s mission to improve health outcomes through effective use of cardiovascular CT. Our innovative technologies across a broad portfolio of CT scanners are designed to optimize workflow efficiency and provide consistent, high-quality images. As the role of cardiovascular CT expands, we strive to empower customers in every setting – from outpatient centers to academic and research hospitals – to offer high quality cardiovascular imaging," said Matthew Dedman, Vice President of Computed Tomography at Siemens Healthineers North America.

At SCCT2024 | Booth 207

• Photon-counting Cardiac CT Challenge: Test your knowledge and be amazed! Join us for a lunch symposium with Dr. Stephan Achenbach, Dr. Angele Kelle, and Dr. Ron Blankstein on Saturday, July 20, at 12:10pm!
• Unlock Dual Source CT for a wider variety of hospitals and facilities with SOMATOM Pro.Pulse. Gold-standard Dual Source CT technology is now combined with myExam Companion for intelligent workflow guidance – at a total cost of ownership comparable to single source scanners.
• Photon-counting for cardiac imaging: By offering intrinsic spectral imaging independent of scan speed and of temporal or spatial resolution, NAEOTOM Alpha redefines which patient populations can be addressed with cardiac CT – even those with heavy calcification or stents. Bring spectral imaging to the coronary vessels and benefit from impressive details for small structures.

About

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care.

Press contact
Liv Egan, Director, CT Product Marketing (SOMATOM Portfolio) 
Olivia.egan@siemens-healthineers.com | (484) 983-9743
 
More information 
www.siemens-healthineers.com

###

About the Society of Cardiovascular Computed Tomography
Founded in 2005, the Society of Cardiovascular Computed Tomography (SCCT) is the international professional society devoted to improving health outcomes through effective use of cardiovascular computed tomography (CCT), with members from over 85 countries. SCCT is a community of physicians, scientists and technologists advocating for access, research, education and clinical excellence in the use of CCT. For more information, please visit https://scct.org/

About the 19th Annual Scientific Meeting of SCCT (SCCT2024) 
SCCT2024 – the preeminent meeting focused on cardiovascular CT – will be held July 18 - 21, 2024 in Washington, DC. The SCCT Annual Scientific Meeting is designed to engage physicians, trainees, technologists and healthcare professionals in a complete overview of the cardiovascular CT field. Planned sessions are targeted for all levels, from new practitioners to experienced providers. Sessions range from general overviews to state-of-the-art research and expert discussions. For more information, please visit https://scct.org/SCCT2024.  

###